Comparison

Pelitrexol European Partner

Item no. TMO-T14147-500mg
Manufacturer TargetMol
CASRN 446022-33-9
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles O=C1C2=C(NC[C@@H](CCC=3SC(C(N[C@@H](CCC(O)=O)C(O)=O)=O)=CC3C)C2)NC(N)=N1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias AG 2037,AG2037
Shipping Condition Cool pack
Available
Manufacturer - Targets
Antifolate|||DHFR|||mTOR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
463.51
Description
Pelitrexol (AG2037) is a GARFT inhibitor, which can inhibit the activity of mTORC1, reduce intracellular guanine nucleotides and block the cell cycle in the s-phase, with antiproliferative activity, and can be used in non-small cell lung cancer.
Pathways
Cell Cycle/Checkpoint|||PI3K/Akt/mTOR signaling|||DNA Damage/DNA Repair|||Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?